Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
chronic kidney disease
4
×
clinical trials
fda
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
europe blog main
europe top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
biofourmis
cancer
glaxosmithkline
immunotherapy
investing
ipo
What
companies
life
science
week
bio
days
ipo
momentum
new
raised
roundup
street
therapeutics
wall
abbvie’s
ahead
arrival
biofourmis
biotech
biotechs
black
bucks
cancer
celebrate
chance
club
continue
continued
corner
crop
day
debut
diamond
diamond’s
exceeded
firms
forward
group
hasn’t
haul
Language
unset
Current search:
national
×
" chronic kidney disease "
×
@xconomy.com
4 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
6 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M